CD8A and neoplasm: As research has historically considered cytotoxic CD8+ T cells to play a primary role in immune-mediated tumor killing, efforts to understand how immunotherapy elicits anti-tumor immunity have focused mainly on CD8+ T cells and MHC-I molecules (Goodman et al., 2020; Shklovskaya et al., 2020).